EUVIMEDEUVIMED entdecken
Fallbericht

Etonitazepyne in counterfeit oxycodone tablets—a fatal case report

Live Midttun iD, Lena J Skarshaug, Hege-Merete Krabseth, Per Ole Mobråten Gundersen, Miriam Hansen, Marianne Birgitte Brekke, Joachim Frost

Journal of Analytical Toxicology · 2026

DOI: 10.1093/jat/bkaf065 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Analytical Toxicology, 2026. Verfasst von Live Midttun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, St. Olav's University Hospital, Trondheim 7030, Norway. Hauptthemen laut MEDLINE: Oxycodone, Counterfeit Drugs, Benzimidazoles, Analgesics, Opioid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzimidazole opioids (nitazenes) are novel synthetic opioid receptor agonists that over the last few years have emerged on recreational drug markets, and their abuse has become a concern worldwide. In particular, limited documentation of their pharmacology and toxicology, along with their unpredictable presence in counterfeit medicines mistaken for established brands, pose significant challenges. Herein, we present a case of fatal intoxication with the nitazene etonitazepyne, after intake of tablets appearing like, and thus mistaken as, oxycodone. The assertion of etonitazepyne’s implication in the case was delayed by several months, due to lack of information about and access to seized tablets. Eventually, an analytical method using liquid chromatography coupled to a Waters Xevo TQ-S tandem quadrupole mass spectrometer was developed and documented. Using this method, etonitazepyne was confirmed in the tablets and quantified at a concentration of 0.32 ng/mL in both femoral blood and vitreous fluid sampled at autopsy of the deceased. The femoral blood concentration is in the lower range compared to previously published etonitazepyne-related deaths. This case illustrates the challenges with detecting nitazenes and the imminent health risk counterfeit products poses, even for experienced drug users.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxycodoneCounterfeit DrugsBenzimidazolesAnalgesics, OpioidHumansTabletsTandem Mass SpectrometryFatal OutcomeChromatography, LiquidMale

Stichwörter der Autor:innen

N-pyrrolidino etonitazenebenzimidazole opioidsetonitazepynenitazenes

Substanzen

OxycodoneCounterfeit DrugsTabletsBenzimidazolesAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, St. Olav's University Hospital, Trondheim 7030, Norway.
  • Deparment of Pathology, St. Olav's University Hospital, Trondheim 7030, Norway.

ORCID-Profile: Live Midttun

Zitieren

APA

Midttun, L., Skarshaug, L. J., Krabseth, H. M., Gundersen, P. O. M., Hansen, M., Brekke, M. B., & Frost, J. (2026). Etonitazepyne in counterfeit oxycodone tablets—a fatal case report. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaf065

Vancouver

Midttun L, Skarshaug LJ, Krabseth HM, Gundersen POM, Hansen M, Brekke MB, et al. Etonitazepyne in counterfeit oxycodone tablets—a fatal case report. Journal of Analytical Toxicology. 2026. doi:10.1093/jat/bkaf065

BibTeX
@article{Midttun2026,
  author = {Midttun, Live and Skarshaug, Lena J and Krabseth, Hege-Merete and Gundersen, Per Ole Mobråten and Hansen, Miriam and Brekke, Marianne Birgitte and Frost, Joachim},
  title = {Etonitazepyne in counterfeit oxycodone tablets—a fatal case report},
  journal = {Journal of Analytical Toxicology},
  year = {2026},
  doi = {10.1093/jat/bkaf065}
}
Kostenlos starten →